The purpose of this study was to elucidate the mechanisms that regulate BACE1-dependent cleavage of IR during diabetes to identify regulatory steps that could be pharmacologically targeted to reduce IR cleavage and improve insulin sensitivity. Here, BACE1 is linked to diabetes mellitus.